Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 11/2017

25.07.2017 | Original Article

Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy

verfasst von: Xu-Feng Zhang, Fabio Bagante, Jeffery Chakedis, Dimitrios Moris, Eliza W. Beal, Matthew Weiss, Irinel Popescu, Hugo P. Marques, Luca Aldrighetti, Shishir K. Maithel, Carlo Pulitano, Todd W. Bauer, Feng Shen, George A. Poultsides, Oliver Soubrane, Guillaume Martel, B. Groot Koerkamp, Alfredo Guglielmi, Endo Itaru, Timothy M. Pawlik

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

The objective of the current study was to investigate both short- and long-term outcomes of patients undergoing curative-intent resection for intrahepatic cholangiocarcinoma (ICC) stratified by extent of hepatic resection relative to overall final pathological margin status.

Methods

One thousand twenty-three patients with ICC who underwent curative-intent resection were identified from a multi-institutional database. Demographic, clinicopathological, and operative data, as well as overall (OS) and recurrence-free survival (RFS) were compared among patients undergoing major and minor resection before and after propensity score matching.

Results

Overall, 608 (59.4%) patients underwent major hepatectomy, while 415 (40.6%) had a minor resection. Major hepatectomy was more frequently performed among patients who had large, multiple, and bilobar tumors. Roughly half of patients (n = 294, 48.4%) developed a postoperative complication following major hepatectomy versus only one fourth of patients (n = 113, 27.2%) after minor resection (p < 0.001). In the propensity model, patients who underwent major hepatectomy had an equivalent OS and RFS versus patients who had a minor hepatectomy (median OS, 38 vs. 37 months, p = 0.556; and median RFS, 20 vs. 18 months, p = 0.635). Patients undergoing major resection had comparable OS and RFS with wide surgical margin (≥10 and 5–9 mm), but improved RFS when surgical margin was narrow (1–4 mm) versus minor resection in the propensity model. In the Cox regression model, tumor characteristics and surgical margin were independently associated with long-term outcome.

Conclusions

Major hepatectomy for ICC was not associated with an overall survival benefit, yet was associated with increased perioperative morbidity. Margin width, rather than the extent of resection, affected long-term outcomes. Radical parenchymal-sparing resection should be advocated if a margin clearance of ≥5 mm can be achieved.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Nathan H, Pawlik TM. Staging of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol 2010; 26(3):269–73.CrossRefPubMed Nathan H, Pawlik TM. Staging of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol 2010; 26(3):269–73.CrossRefPubMed
2.
Zurück zum Zitat Mavros MN, Economopoulos KP, Alexiou VG, et al. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 2014; 149(6):565–74.CrossRefPubMed Mavros MN, Economopoulos KP, Alexiou VG, et al. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 2014; 149(6):565–74.CrossRefPubMed
4.
Zurück zum Zitat Saha SK, Zhu AX, Fuchs CS, et al. Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise. Oncologist 2016; 21(5):594–9.CrossRefPubMedPubMedCentral Saha SK, Zhu AX, Fuchs CS, et al. Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise. Oncologist 2016; 21(5):594–9.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 2014; 60(6):1268–89.CrossRefPubMed Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 2014; 60(6):1268–89.CrossRefPubMed
6.
Zurück zum Zitat Zhou XD, Tang ZY, Fan J, et al. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 2009; 135(8):1073–80.CrossRefPubMed Zhou XD, Tang ZY, Fan J, et al. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 2009; 135(8):1073–80.CrossRefPubMed
8.
Zurück zum Zitat Spolverato G, Yakoob MY, Kim Y, et al. The impact of surgical margin status on long-term outcome after resection for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2015; 22(12):4020–8.CrossRefPubMed Spolverato G, Yakoob MY, Kim Y, et al. The impact of surgical margin status on long-term outcome after resection for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2015; 22(12):4020–8.CrossRefPubMed
9.
Zurück zum Zitat Spolverato G, Kim Y, Alexandrescu S, et al. Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection. Ann Surg Oncol 2016; 23(1):235–43.CrossRefPubMed Spolverato G, Kim Y, Alexandrescu S, et al. Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection. Ann Surg Oncol 2016; 23(1):235–43.CrossRefPubMed
10.
Zurück zum Zitat Spolverato G, Ejaz A, Kim Y, et al. Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma. J Gastrointest Surg 2014; 18(7):1284–91.CrossRefPubMed Spolverato G, Ejaz A, Kim Y, et al. Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma. J Gastrointest Surg 2014; 18(7):1284–91.CrossRefPubMed
11.
Zurück zum Zitat Hyder O, Hatzaras I, Sotiropoulos GC, et al. Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery 2013; 153(6):811–8.CrossRefPubMedPubMedCentral Hyder O, Hatzaras I, Sotiropoulos GC, et al. Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery 2013; 153(6):811–8.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Terminology Committee of the IHPBA. Terminology of liver anatomy and resections. HPB (Oxford) 2000; 2:333–339.CrossRef Terminology Committee of the IHPBA. Terminology of liver anatomy and resections. HPB (Oxford) 2000; 2:333–339.CrossRef
13.
Zurück zum Zitat Ubink I, Jongen JM, Nijkamp MW, et al. Surgical and oncologic outcomes after major liver surgery and extended hemihepatectomy for colorectal liver metastases. Clin Colorectal Cancer 2016; 15(4):e193-e198.CrossRefPubMed Ubink I, Jongen JM, Nijkamp MW, et al. Surgical and oncologic outcomes after major liver surgery and extended hemihepatectomy for colorectal liver metastases. Clin Colorectal Cancer 2016; 15(4):e193-e198.CrossRefPubMed
14.
Zurück zum Zitat Yasui M, Harada A, Torii A, et al. Impaired liver function and long-term prognosis after hepatectomy for hepatocellular carcinoma. World J Surg 1995; 19(3):439–43.CrossRefPubMed Yasui M, Harada A, Torii A, et al. Impaired liver function and long-term prognosis after hepatectomy for hepatocellular carcinoma. World J Surg 1995; 19(3):439–43.CrossRefPubMed
15.
Zurück zum Zitat Nadig DE, Wade TP, Fairchild RB, et al. Major hepatic resection. Indications and results in a national hospital system from 1988 to 1992. Arch Surg 1997; 132(2):115–9.CrossRefPubMed Nadig DE, Wade TP, Fairchild RB, et al. Major hepatic resection. Indications and results in a national hospital system from 1988 to 1992. Arch Surg 1997; 132(2):115–9.CrossRefPubMed
16.
Zurück zum Zitat Dahiya D, Wu TJ, Lee CF, et al. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience. Surgery 2010; 147(5):676–85.CrossRefPubMed Dahiya D, Wu TJ, Lee CF, et al. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience. Surgery 2010; 147(5):676–85.CrossRefPubMed
17.
Zurück zum Zitat Regimbeau JM, Kianmanesh R, Farges O, et al. Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery 2002; 131(3):311–7.CrossRefPubMed Regimbeau JM, Kianmanesh R, Farges O, et al. Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery 2002; 131(3):311–7.CrossRefPubMed
18.
Zurück zum Zitat Stewart GD, O'Suilleabhain CB, Madhavan KK, et al. The extent of resection influences outcome following hepatectomy for colorectal liver metastases. Eur J Surg Oncol 2004; 30(4):370–6.CrossRefPubMed Stewart GD, O'Suilleabhain CB, Madhavan KK, et al. The extent of resection influences outcome following hepatectomy for colorectal liver metastases. Eur J Surg Oncol 2004; 30(4):370–6.CrossRefPubMed
19.
Zurück zum Zitat Couinaud C. Liver anatomy: portal (and suprahepatic) or biliary segmentation. Dig Surg 1999; 16(6):459–67.CrossRefPubMed Couinaud C. Liver anatomy: portal (and suprahepatic) or biliary segmentation. Dig Surg 1999; 16(6):459–67.CrossRefPubMed
20.
Zurück zum Zitat Edge S BD, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer, 2010. Edge S BD, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer, 2010.
21.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240(2):205–13.CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240(2):205–13.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 2011; 29(23):3140–5.CrossRefPubMed de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 2011; 29(23):3140–5.CrossRefPubMed
23.
Zurück zum Zitat Bagante F, Spolverato G, Cucchetti A, et al. Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: a regret-based decision curves analysis. Surgery 2016; 160(1):106–17.CrossRefPubMed Bagante F, Spolverato G, Cucchetti A, et al. Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: a regret-based decision curves analysis. Surgery 2016; 160(1):106–17.CrossRefPubMed
25.
Zurück zum Zitat Torzilli G, Makuuchi M, Inoue K, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999; 134(9):984–92.CrossRefPubMed Torzilli G, Makuuchi M, Inoue K, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999; 134(9):984–92.CrossRefPubMed
26.
Zurück zum Zitat Lang BH, Poon RT, Fan ST, et al. Perioperative and long-term outcome of major hepatic resection for small solitary hepatocellular carcinoma in patients with cirrhosis. Arch Surg 2003; 138(11):1207–13.CrossRefPubMed Lang BH, Poon RT, Fan ST, et al. Perioperative and long-term outcome of major hepatic resection for small solitary hepatocellular carcinoma in patients with cirrhosis. Arch Surg 2003; 138(11):1207–13.CrossRefPubMed
27.
Zurück zum Zitat Poon RT, Fan ST, Lo CM, et al. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol 2000; 18(5):1094–101.CrossRefPubMed Poon RT, Fan ST, Lo CM, et al. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol 2000; 18(5):1094–101.CrossRefPubMed
28.
Zurück zum Zitat Simonetti RG, Camma C, Fiorello F, et al. Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 1991; 36(7):962–72.CrossRefPubMed Simonetti RG, Camma C, Fiorello F, et al. Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 1991; 36(7):962–72.CrossRefPubMed
29.
Zurück zum Zitat Farges O, Malassagne B, Flejou JF, et al. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 1999; 229(2):210–5.CrossRefPubMedPubMedCentral Farges O, Malassagne B, Flejou JF, et al. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 1999; 229(2):210–5.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Kumada T, Nakano S, Takeda I, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 1997; 25(1):87–92.CrossRefPubMed Kumada T, Nakano S, Takeda I, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 1997; 25(1):87–92.CrossRefPubMed
31.
Zurück zum Zitat Kaibori M, Matsui Y, Hijikawa T, et al. Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C. Surgery 2006; 139(3):385–94.CrossRefPubMed Kaibori M, Matsui Y, Hijikawa T, et al. Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C. Surgery 2006; 139(3):385–94.CrossRefPubMed
32.
Zurück zum Zitat Karanjia ND, Lordan JT, Quiney N, et al. A comparison of right and extended right hepatectomy with all other hepatic resections for colorectal liver metastases: a ten-year study. Eur J Surg Oncol 2009; 35(1):65–70.CrossRefPubMed Karanjia ND, Lordan JT, Quiney N, et al. A comparison of right and extended right hepatectomy with all other hepatic resections for colorectal liver metastases: a ten-year study. Eur J Surg Oncol 2009; 35(1):65–70.CrossRefPubMed
33.
Zurück zum Zitat Moris D, Ronnekleiv-Kelly S, Rahnemai-Azar AA, Felekouras E, Dillhoff M, Schmidt C, Pawlik TM. Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review. J Gastrointest Surg 2017; 21(6):1076–1085. doi:10.1007/s11605-017-3397-y. Moris D, Ronnekleiv-Kelly S, Rahnemai-Azar AA, Felekouras E, Dillhoff M, Schmidt C, Pawlik TM. Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review. J Gastrointest Surg 2017; 21(6):1076–1085. doi:10.​1007/​s11605-017-3397-y.
34.
Zurück zum Zitat Grazi GL, Ercolani G, Pierangeli F, et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 2001; 234(1):71–8.CrossRefPubMedPubMedCentral Grazi GL, Ercolani G, Pierangeli F, et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 2001; 234(1):71–8.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Spolverato G, Yakoob MY, Kim Y, et al. Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinoma. Cancer 2015; 121(16):2730–9.CrossRefPubMed Spolverato G, Yakoob MY, Kim Y, et al. Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinoma. Cancer 2015; 121(16):2730–9.CrossRefPubMed
Metadaten
Titel
Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy
verfasst von
Xu-Feng Zhang
Fabio Bagante
Jeffery Chakedis
Dimitrios Moris
Eliza W. Beal
Matthew Weiss
Irinel Popescu
Hugo P. Marques
Luca Aldrighetti
Shishir K. Maithel
Carlo Pulitano
Todd W. Bauer
Feng Shen
George A. Poultsides
Oliver Soubrane
Guillaume Martel
B. Groot Koerkamp
Alfredo Guglielmi
Endo Itaru
Timothy M. Pawlik
Publikationsdatum
25.07.2017
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 11/2017
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-017-3499-6

Weitere Artikel der Ausgabe 11/2017

Journal of Gastrointestinal Surgery 11/2017 Zur Ausgabe

Evidence-Based Current Surgical Practice

Management of Post-Bariatric Surgery Emergencies

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.